Clinical Trials Browser

Phase EARLY_PHASE1 × Ferrosoferric Oxide × Clear all

NCT04369560 2025-12-17

Virtual Histology of the Bladder Wall for Bladder Cancer Staging

Phase EARLY_PHASE1 Recruiting

Urinary Bladder Neoplasms

NCT03179449 2023-04-14

In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI

Phase EARLY_PHASE1 Withdrawn

Childhood Brain Neoplasm

NCT00978562 2022-08-03

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

Phase EARLY_PHASE1 Completed

14 enrolled 8 charts

Childhood Brain Neoplasm

NCT01895829 2021-09-21

Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI

Phase EARLY_PHASE1 Terminated

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02857218 2021-09-16

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

Phase EARLY_PHASE1 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT03280277 2021-09-10

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Rectal Neoplasms

NCT02466828 2018-04-18

qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.

Phase EARLY_PHASE1 Completed

Hypoxia, Glioblastoma

NCT02452216 2017-08-31

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Phase EARLY_PHASE1 Completed

Ischemic Stroke, Hemorrhagic Stroke, Brain Injuries, Brain Neoplasms, Central Nervous System Infections, Neurodegenerative Diseases, Central Nervous System Vascular Malformations